Review
Open access
Sep 2026
Engineering next-generation CAR-T cells for glioblastoma treatment: a review of innovations in receptor design, antigen targeting, and therapeutic persistence.
It is indicated that no single engineering strategy is sufficient to overcome the interconnected barriers of GBM, and future progress in GBM CAR therapy will therefore depend on combining complementary solutions rather than improving only one CAR feature.
Aleksandra Królikowska, Katarzyna Białkowska
· International Immunopharmaco... · 0 citations